Leukemia & Lymphoma, Volume 63, Issue 1 (2022)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 63, Issue 1 (2022)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Volume 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Article commentaries

Article Commentary
A PET in a time of need: toward early PET-adapted therapy in DLBCL in first relapse
Adrian Minson, Michael Hofman & Michael Dickinson
Pages: 1-4
Published online: 17 Dec 2021
AbstractforA PET in a time of need: toward early PET-adapted therapy in DLBCL in first relapse | Full Text | References | PDF (681.1 KB) | EPUB
  • 180 Views
  • 1 CrossRef citations
  • 0Altmetric
Article Commentary
Prediction for sustained deep molecular response for treatment-free remission
Koji Sasaki, Hagop Kantarjian & Elias Jabbour
Pages: 5-6
Published online: 21 Dec 2021
CitationforPrediction for sustained deep molecular response for treatment-free remission | Full Text | References | PDF (236.2 KB) | EPUB
  • 81 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Allogeneic transplant graft source – conditioning – GVHD prophylaxis: don’t mix and match!
Alexandra Gomez-Arteaga & Koen van Besien
Pages: 7-9
Published online: 24 Nov 2021
First Page PreviewforAllogeneic transplant graft source – conditioning – GVHD prophylaxis: don’t mix and match! | Full Text | References | PDF (403.9 KB) | EPUB
  • 174 Views
  • 1 CrossRef citations
  • 0Altmetric

Reviews

Niche-directed therapy in acute myeloid leukemia: optimization of stem cell competition for niche occupancy
Shyam A. Patel, Disha Dalela, Amy C. Fan, Maxwell R. Lloyd & Tian Y. Zhang
Pages: 10-18
Published online: 19 Aug 2021
AbstractforNiche-directed therapy in acute myeloid leukemia: optimization of stem cell competition for niche occupancy | Full Text | References | PDF (1.1 MB) | EPUB
  • 457 Views
  • 3 CrossRef citations
  • 0Altmetric
CD303 (BDCA-2) – a potential novel target for therapy in hematologic malignancies
Nathaniel R. Wilson, Laura Bover, Marina Konopleva, Lina Han, Sattva Neelapu & Naveen Pemmaraju
Pages: 19-30
Published online: 06 Sep 2021
AbstractforCD303 (BDCA-2) – a potential novel target for therapy in hematologic malignancies | Full Text | References | PDF (1.3 MB) | EPUB
  • 740 Views
  • 5 CrossRef citations
  • 0Altmetric

Original Articles

Article
CD5 expression in marginal zone lymphoma predicts differential response to rituximab or bendamustine/rituximab
Andrew Hsu, Habibe Kurt, Adam S. Zayac & Adam J. Olszewski
Pages: 31-42
Published online: 01 Sep 2021
AbstractforCD5 expression in marginal zone lymphoma predicts differential response to rituximab or bendamustine/rituximab | Full Text | References | PDF (2.7 MB) | EPUB | Supplemental
  • 386 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Prognostic value of presalvage metabolic tumor volume in patients with relapsed/refractory diffuse large B-cell lymphoma
Juan Pablo Alderuccio, Russ A. Kuker, Priscila Barreto-Coelho, Bianca M. Martinez, Feng Miao, Deukwoo Kwon, Amer Beitinjaneh, Trent P. Wang, Isildinha M. Reis, Izidore S. Lossos & Craig H. Moskowitz
Pages: 43-53
Published online: 20 Aug 2021
AbstractforPrognostic value of presalvage metabolic tumor volume in patients with relapsed/refractory diffuse large B-cell lymphoma | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 315 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Epidemiology of diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) in the United States and Western Europe: population-level projections for 2020–2025
Gena Kanas, Wenzhen Ge, Ruben G. W. Quek, Katie Keeven, Knar Nersesyan & Jon E. Arnason
Pages: 54-63
Published online: 11 Sep 2021
AbstractforEpidemiology of diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) in the United States and Western Europe: population-level projections for 2020–2025 | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 21823 Views
  • 16 CrossRef citations
  • 0Altmetric
Open Access
Article
Risk factors for severe infections in secondary immunodeficiency: a retrospective US administrative claims study in patients with hematological malignancies
Stephen Jolles, B. Douglas Smith, Donald C. Vinh, Rajiv Mallick, Gabriela Espinoza, Mitchell DeKoven & Victoria Divino
Pages: 64-73
Published online: 26 Oct 2021
AbstractforRisk factors for severe infections in secondary immunodeficiency: a retrospective US administrative claims study in patients with hematological malignancies | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 3084 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Article
A prospective study on early PET/CT scans during the first cycle of salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma
Hua-Jay J. Cherng, Hubert H. Chuang, Raphael Steiner, Luis Fayad, Paolo Strati, Ranjit Nair, Fredrick Hagemeister, Loretta J. Nastoupil, Hun Ju Lee, Sattva S. Neelapu, Christopher R. Flowers, Felipe Samaniego, Maria Rodriguez, Homer A. Macapinlac, Lei Feng & Jason Westin
Pages: 74-83
Published online: 26 Aug 2021
AbstractforA prospective study on early PET/CT scans during the first cycle of salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma | Full Text | References | PDF (1.8 MB) | EPUB | Supplemental
  • 337 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma – first analysis of toxicity and efficacy signals
Sophy Denker, Aitomi Bittner, Mareike Frick, Julia Kase, Jörg Hoffmann, Corinna Trenker, Ulrich Keller, Christian Bogner, Andreas Hüttmann, Jan Dürig, Martin Janz, Stephan Mathas, Reinhard Marks, Ulrike Krohn, Il-Kang Na, Lars Bullinger & Clemens A. Schmitt
Pages: 84-92
Published online: 20 Aug 2021
AbstractforIbrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma – first analysis of toxicity and efficacy signals | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 492 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
A randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results
Armando López-Guillermo, Miguel Ángel Canales, Ivan Dlouhy, Santiago Mercadal, Javier Briones, Alejandro Martín García-Sancho, Juan Manuel Sancho, José María Moraleda, María José Terol, Antonio Salar, Luis Palomera, Santiago Gardella, Isidro Jarque, Secundino Ferrer, Joan Bargay, Andrés López, Carlos Panizo, Anna Muntañola, Carlos Montalbán, Eulogio Conde, Miguel T. Hernández, Alfons Soler, José A. García Marco, Guillermo Deben, Julián Marín, José Francisco Tomás & for the PETHEMA/GELTAMO/GELCAB Spanish Intergroup
Pages: 93-100
Published online: 30 Aug 2021
AbstractforA randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 285 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
BCL2 translocation in high grade B cell lymphoma (NOS, DH/TH) is associated with reduced progression free survival
Sonia Gonzalez de Villambrosia, Mariana Bastos, Javier Menarguez Palanca, Jorge Gayoso Cruz, José-Tomás Navarro, Gustavo Tapia, Sara Alvarez Alonso, Alejandro Martin, Oscar Blanco, Pau Abrisqueta, Josep Castellvi, Ana García-Noblejas, Reyes Arranz, Magdalena Adrados, Andrés López, Santiago Montes-Moreno & On behalf of Grupo Español de linfomas y trasplante (GELTAMO)
Pages: 101-108
Published online: 11 Sep 2021
AbstractforBCL2 translocation in high grade B cell lymphoma (NOS, DH/TH) is associated with reduced progression free survival | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 219 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Clinical characteristics and prognostic factors of 70 patients with Sézary syndrome: a single-institutional experience at Moffitt cancer center
Yumeng Zhang, Lucia Seminario-Vidal, Christa Varnadoe, Yuanyuan Lu, Ning Dong, Christopher Salamanca, Shannen Whiddon, Janice Bennett, Rebecca Hargis, Hien Liu, Michael Montejo, Mohammad Hussaini, Carly Harro, Jane Messina, Kaaron Benson, Javier Pinilla-Ibarz, Jose Conejo-Garcia & Lubomir Sokol
Pages: 109-116
Published online: 01 Sep 2021
AbstractforClinical characteristics and prognostic factors of 70 patients with Sézary syndrome: a single-institutional experience at Moffitt cancer center | Full Text | References | PDF (954.3 KB) | EPUB | Supplemental
  • 377 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
A phase I trial of inotuzumab ozogamicin in combination with temsirolimus in patients with relapsed or refractory CD22-positive B-cell non-Hodgkin lymphomas
Maria C. Pirosa, Lu Zhang, Felicitas Hitz, Urban Novak, Dagmar Hess, Tatiana Terrot, Mariarosa Pascale, Luca Mazzucchelli, Francesco Bertoni, Franco Cavalli, Emanuele Zucca & Anastasios Stathis
Pages: 117-123
Published online: 19 Aug 2021
AbstractforA phase I trial of inotuzumab ozogamicin in combination with temsirolimus in patients with relapsed or refractory CD22-positive B-cell non-Hodgkin lymphomas | Full Text | References | PDF (566.6 KB) | EPUB
  • 226 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Prognostic significance of serum β2-microglobulin levels in patients with peripheral T-cell lymphoma not otherwise specified
Hyung-Don Kim, Hyungwoo Cho, Byeong Seok Sohn, Chan-Sik Park, Jooryung Huh, Jin Sook Ryu, Sang-Wook Lee, Sang Eun Yoon, Seok Jin Kim, Young Hyeh Ko, Won Seog Kim & Cheolwon Suh
Pages: 124-130
Published online: 26 Oct 2021
AbstractforPrognostic significance of serum β2-microglobulin levels in patients with peripheral T-cell lymphoma not otherwise specified | Full Text | References | PDF (1.2 MB) | EPUB
  • 198 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Patient characteristics, treatment patterns, and mortality in elderly patients newly diagnosed with acute myeloid leukemia meeting ineligibility criteria for high intensity chemotherapy
Shuling Li, Yuanyuan Ji, Yi Peng, Vamsi Kota & Christopher Kim
Pages: 131-141
Published online: 13 Oct 2021
AbstractforPatient characteristics, treatment patterns, and mortality in elderly patients newly diagnosed with acute myeloid leukemia meeting ineligibility criteria for high intensity chemotherapy | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 1844 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Comparative analysis of infectious complications with outpatient vs. inpatient care for adults with high-risk myeloid neoplasm receiving intensive induction chemotherapy
Anna B. Halpern, Megan Othus, Nicholas P. Howard, Paul C. Hendrie, Mary-Elizabeth M. Percival, Garrett A. Hartley, Verna L. Welch, Elihu H. Estey & Roland B. Walter
Pages: 142-151
Published online: 05 Oct 2021
AbstractforComparative analysis of infectious complications with outpatient vs. inpatient care for adults with high-risk myeloid neoplasm receiving intensive induction chemotherapy | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 216 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Prognostic significance of TIM-3 expression pattern at diagnosis in patients with t(8;21) acute myeloid leukemia
Jun Wang, Lu Yang, Feng-Ting Dao, Ya-Zhe Wang, Yan Chang, Nan Xu, Wen-Min Chen, Qian Jiang, Hao Jiang, Yan-Rong Liu & Ya-Zhen Qin
Pages: 152-161
Published online: 18 Aug 2021
AbstractforPrognostic significance of TIM-3 expression pattern at diagnosis in patients with t(8;21) acute myeloid leukemia | Full Text | References | PDF (1.3 MB) | EPUB
  • 307 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Early prediction of stable MR4.5 by depth of molecular response at 6 months in patients with chronic myeloid leukemia treated with frontline imatinib
Aisling Nee, Jeffrey H. Lipton & Dennis Dong Hwan Kim
Pages: 162-169
Published online: 11 Aug 2021
AbstractforEarly prediction of stable MR4.5 by depth of molecular response at 6 months in patients with chronic myeloid leukemia treated with frontline imatinib | Full Text | References | PDF (798.6 KB) | EPUB | Supplemental
  • 173 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Acute lymphoblastic leukemia (ALL) in adults: disparities in treatment intervention based on access to treatment facility
Karishma Khullar, Jesse J. Plascak & Rahul R. Parikh
Pages: 170-178
Published online: 08 Sep 2021
AbstractforAcute lymphoblastic leukemia (ALL) in adults: disparities in treatment intervention based on access to treatment facility | Full Text | References | PDF (829.5 KB) | EPUB
  • 194 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Association of creatine kinase elevation with clinical outcomes in chronic myeloid leukemia: a retrospective cohort study
Aniket Bankar & Jeffrey H. Lipton
Pages: 179-188
Published online: 08 Sep 2021
AbstractforAssociation of creatine kinase elevation with clinical outcomes in chronic myeloid leukemia: a retrospective cohort study | Full Text | References | PDF (1.7 MB) | EPUB | Supplemental
  • 197 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Adherence to ruxolitinib, an oral JAK1/2 inhibitor, in patients with myelofibrosis: interim analysis from an Italian, prospective cohort study (ROMEI)
Paola Guglielmelli, Francesca Palandri, Carmine Selleri, Daniela Cilloni, Francesco Mendicino, Patrizio Mazza, Domenico Pastore, Giuseppe A. Palumbo, Marco Santoro, Vincenzo Pavone, Stefana Impera, Mara Morelli, Paola Coco, Diletta Valsecchi, Francesco Passamonti, Massimo Breccia & on behalf of the ROMEI study group
Pages: 189-198
Published online: 15 Sep 2021
AbstractforAdherence to ruxolitinib, an oral JAK1/2 inhibitor, in patients with myelofibrosis: interim analysis from an Italian, prospective cohort study (ROMEI) | Full Text | References | PDF (1.1 MB) | EPUB
  • 520 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Treatment outcomes for patients with myelodysplastic syndrome/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis
Rami Komrokji, Megan Melody, Najla al Ali, Onyee Chan, Virginia Klimek, Brian J. Ball, Mikkael A. Sekeres, George Lucas, Jaroslaw P. Maciejewski, David A. Sallman, Eric Padron, Andrew Kuykendall, Terra Lasho, Aref Al-Kali, Kiran Naqvi, David P. Steensma, Guillermo Garcia-Manero & Mrinal M. Patnaik
Pages: 199-204
Published online: 27 Aug 2021
AbstractforTreatment outcomes for patients with myelodysplastic syndrome/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis | Full Text | References | PDF (1.2 MB) | EPUB
  • 600 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
A nationwide prospective registry of bortezomib-based therapy in light chain (AL) amyloidosis
Giovanni Palladini, Simone Celant, Paolo Milani, Valentina Summa, Giovanni Affronti, Pier Paolo Olimpieri, Sandra Petraglia, Andrea Foli, Mario Nuvolone, Giampaolo Merlini, Pierluigi Russo & on behalf of the AIFA’s Monitoring Registries Group
Pages: 205-211
Published online: 27 Aug 2021
AbstractforA nationwide prospective registry of bortezomib-based therapy in light chain (AL) amyloidosis | Full Text | References | PDF (1 MB) | EPUB
  • 200 Views
  • 5 CrossRef citations
  • 0Altmetric

Letters to the Editor

Letter
Chronic myeloid leukemia with pure erythroid leukemia blast crisis
Jeremy W. Jacobs, Rahul Ramaswamy, Vanessa States, Jennifer Reppucci, Olalekan O. Oluwole, Emily F. Mason & Mary Ann Thompson
Pages: 212-216
Published online: 06 Sep 2021
AbstractforChronic myeloid leukemia with pure erythroid leukemia blast crisis | Full Text | References | PDF (1.4 MB) | EPUB
  • 386 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Immune reconstitution following rituximab-based immunochemotherapy in pediatric patients with B-cell non-Hodgkin lymphomas
Alexandra Semchenkova, Vladimir Zhogov, Anastassia Rudneva, Liudmila Potapenko, Svetlana Plyasunova, Natalia Miakova, Elena Samochatova, Alexey Maschan & Alexander Popov
Pages: 217-221
Published online: 02 Nov 2021
First Page PreviewforImmune reconstitution following rituximab-based immunochemotherapy in pediatric patients with B-cell non-Hodgkin lymphomas | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 162 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Increased early mortality after fludarabine and melphalan conditioning with peripheral blood grafts in haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide
Luke Eastburg, David A. Russler-Germain, John F. DiPersio, Thomas Fountaine, Jeffrey R. Andolina, Ramzi Abboud & Eric Huselton
Pages: 222-226
Published online: 18 Nov 2021
AbstractforIncreased early mortality after fludarabine and melphalan conditioning with peripheral blood grafts in haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide | Full Text | References | PDF (1.3 MB) | EPUB
  • 1606 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Letter
Improvement in mortality of hospitalized patients with hematological malignancies in the 2nd wave of COVID-19 in the UK: experience of a large London NHS trust
Richard Hinton, George Nesr, Catherine Garnett, David Foldes, Joel James Robert McCay, Rachael Medland, Huseini Kagdi, Vaitsa Katsomitrou, Hau Wui Sim, Sameer Gandhi, Agapi Parcharidou & Siamak Arami
Pages: 227-230
Published online: 02 Sep 2021
First Page PreviewforImprovement in mortality of hospitalized patients with hematological malignancies in the 2nd wave of COVID-19 in the UK: experience of a large London NHS trust | Full Text | References | PDF (886.8 KB) | EPUB
  • 142 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Allogeneic hematopoietic cell transplantation using non-myeloablative ATG/TLI conditioning for lymphomas
Tamer Othman, Benjamin N. Moskoff, Naseem Esteghamat, Rasmus T. Hoeg, Aaron S. Rosenberg, Brian A. Jonas, Mehrdad Abedi, Carol Richman & Joseph M. Tuscano
Pages: 231-234
Published online: 06 Sep 2021
First Page PreviewforAllogeneic hematopoietic cell transplantation using non-myeloablative ATG/TLI conditioning for lymphomas | Full Text | References | PDF (666.1 KB) | EPUB
  • 146 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Well-differentiated systemic mastocytosis with associated myeloid sarcoma and myelodysplastic syndrome: Diagnostic challenges of an underrecognized entity
Siba El Hussein, Shimin Hu, Hong Fang, Sofia Garces, Tariq Muzzafar, Sa A. Wang, L. Jeffrey Medeiros, Carlos Bueso-Ramos & Fatima Zahra Jelloul
Pages: 235-238
Published online: 11 Sep 2021
First Page PreviewforWell-differentiated systemic mastocytosis with associated myeloid sarcoma and myelodysplastic syndrome: Diagnostic challenges of an underrecognized entity | Full Text | References | PDF (1.7 MB) | EPUB
  • 210 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Panuveitis induced by brentuximab vedotin: a possible novel adverse event of an antibody-drug conjugate
Philippos Apolinario Costa, Andrea Patricia Espejo-Freire, Kenneth Chen Fan, Thomas Arno Albini & Georgios Pongas
Pages: 239-242
Published online: 13 Sep 2021
First Page PreviewforPanuveitis induced by brentuximab vedotin: a possible novel adverse event of an antibody-drug conjugate | Full Text | References | PDF (672.5 KB) | EPUB
  • 196 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Time-to-response for patients with relapsed/refractory diffuse large B cell and high grade B cell lymphoma treated with polatuzumab-based therapy
Daniel J. Landsburg, Sunita D. Nasta, James N. Gerson, Jakub Svoboda, Elise A. Chong, Stephen J. Schuster, Stefan K. Barta, Kyle W. Robinson & Mitchell E. Hughes
Pages: 243-246
Published online: 26 Aug 2021
First Page PreviewforTime-to-response for patients with relapsed/refractory diffuse large B cell and high grade B cell lymphoma treated with polatuzumab-based therapy | Full Text | References | PDF (589.4 KB) | EPUB
  • 659 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Primary neurolymphomatosis in extranodal natural killer/T-cell lymphoma diagnosed by skin biopsy
Chung-Hao Hsu, Chi-Shun Yang, Yi-Ju Chen & Teng-Li Lin
Pages: 247-249
Published online: 27 Aug 2021
First Page PreviewforPrimary neurolymphomatosis in extranodal natural killer/T-cell lymphoma diagnosed by skin biopsy | Full Text | References | PDF (1,014.3 KB) | EPUB | Supplemental
  • 63 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Looking for somatic mutations in UBA1 in patients with chronic myelomonocytic leukemia associated with systemic inflammation and autoimmune diseases
Henry Dupuy, Charles Dussiau, Audrey Bidet, Mathieu Sauvezie, Anne-Charlotte De-Grande, Joël Decombe, Étienne Rivière, Edouard Forcade, Fabrice Bonnet, Pierre-Yves Dumas, Pierre Duffau, Arnaud Pigneux, Jean-François Viallard, Estibaliz Lazaro & Sophie Dimicoli-Salazar
Pages: 250-252
Published online: 03 Sep 2021
First Page PreviewforLooking for somatic mutations in UBA1 in patients with chronic myelomonocytic leukemia associated with systemic inflammation and autoimmune diseases | Full Text | References | PDF (310.5 KB) | EPUB
  • 343 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Worsening of COVID-19 after chemotherapy in patients considered to have recovered from a SARS-CoV-2 infection
Arthur Poncelet, Gil Verschelden, Martin Colard, Marc Hildebrand, Maya Hites, Nicolas Yin, Charlotte Michel, David Grimaldi & Virginie De Wilde
Pages: 253-255
Published online: 15 Sep 2021
First Page PreviewforWorsening of COVID-19 after chemotherapy in patients considered to have recovered from a SARS-CoV-2 infection | Full Text | References | PDF (306.9 KB) | EPUB
  • 140 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Prognostication of diffuse large B-cell lymphoma patients with Deauville score of 3 or 4 at end-of-treatment PET evaluation: a comparison of the Deauville 5-point scale and the ΔSUVmax method
David Z. Ng, Chuan Yaw Lee, Winnie W. Lam, Aaron K. Tong, Sze Huey Tan, Lay Poh Khoo, Ya Hwee Tan, Jianbang Chiang, Esther W. Chang, Jason Y. Chan, Eileen Y. Poon, Nagavalli Somasundaram, Mohamed Farid H. Rashid, Miriam Tao, Soon Thye Lim & Valerie S. Yang
Pages: 256-259
Published online: 19 Oct 2021
AbstractforPrognostication of diffuse large B-cell lymphoma patients with Deauville score of 3 or 4 at end-of-treatment PET evaluation: a comparison of the Deauville 5-point scale and the ΔSUVmax method | Full Text | References | PDF (672.9 KB) | EPUB
  • 3528 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Explore articles

Explore the most recently published articles

Outcomes of patients aged ≥26 years with relapsed or refractory B-cell acute lymphoblastic leukemia in ZUMA-3 and historical trials
Monique C. Minnema et al.
Article | Published online: 24 May 2024
Open Access
Acceleration of non-Hodgkin lymphoma progression during pregnancy in a murine model
Netanel A. Horowitz et al.
Letter to the Editor | Published online: 23 May 2024
Zanubrutinib is effective in non-germinal-center B-cell-like diffuse large B-cell lymphoma with mutated CD79B, high TCL1A expression, or over- expressed MYC/BCL-2
Yang Liu et al.
Article | Published online: 22 May 2024
Open Access
Immune escape of B-cell lymphoblastic leukemic cells through a lineage switch to acute myeloid leukemia
Karolina Bełdzińska-Gądek et al.
Article | Published online: 22 May 2024
View all latest articles